Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction PEG-Intron + Rebetol in Chronic Hepatitis C
NCT00207363Phase 4Completed
- Sponsor
- Brooke Army Medical Center
- Start
- Feb 2002
- Primary completion
- Jan 2010
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2b in hepatitis C (HCV), sponsored by Brooke Army Medical Center. Started Feb 2002; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00207363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00207363.